Mäkelä A, Kuusi T, Somerharju P, Schröder T
Second Department of Surgery, Faculty of Medicine, University of Helsinki, Finland.
Scand J Clin Lab Invest. 1987 Oct;47(6):529-34. doi: 10.1080/00365518709168464.
An assay using 2-(1-14C)palmitoyl-labelled dipalmitoyl phosphatidylcholine substrate for the determination of serum phospholipase A2 (PLA2) activity is described and validated. The rapid determination of the enzyme activity is enabled by a simple liquid-liquid partition system to replace the laborious thin-layer chromatography used in earlier studies. The PLA2 activity of human pancreatic juice was used for the optimization of the assay. Interference by serum phospholipids can be avoided by using 10 microliter aliquots of serum in the assay, whereas larger amounts caused a progressive inhibition of the enzyme activity. Virtually no enzyme activity is determined in serum from normal healthy subjects (range from 1.2 to 3.0 IU/l). In acute haemorrhagic pancreatitis the PLA2 activity is markedly elevated (range from 10.7 to 42.0 IU/l). Due to the simple extraction of the reaction products the results can be obtained the same day. Therefore, the assay can conveniently be used for the rapid clinical identification of subjects with acute haemorrhagic pancreatitis.
本文描述并验证了一种使用2-(1-¹⁴C)棕榈酰标记的二棕榈酰磷脂酰胆碱底物来测定血清磷脂酶A2(PLA2)活性的分析方法。通过简单的液-液分配系统能够快速测定酶活性,取代了早期研究中使用的繁琐的薄层色谱法。人胰液的PLA2活性用于该分析方法的优化。在分析中使用10微升血清等分试样可避免血清磷脂的干扰,而使用较大量血清会导致酶活性逐渐受到抑制。正常健康受试者的血清中几乎检测不到酶活性(范围为1.2至3.0 IU/L)。在急性出血性胰腺炎中,PLA2活性显著升高(范围为10.7至42.0 IU/L)。由于反应产物的提取简单,可在当天获得结果。因此,该分析方法可方便地用于急性出血性胰腺炎患者的快速临床诊断。